Retinopathy of Prematurity: Two Distinct Mechanisms That Underlie Zone 1 and Zone 2 Disease

American Journal of Ophthalmology

Volumn 142, Issue 1, 2006, Pages

  Flynn, John T ^a   Chan Ling, Tailoi ^b  

^a Edward S Harkness Eye Institute   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CRYOTHERAPY; DIGITAL IMAGING; DISEASE PREDISPOSITION; HUMAN; HYPOXIA; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; REMISSION; RETINA; RETROLENTAL FIBROPLASIA; TREATMENT OUTCOME; VASCULARIZATION; VISION;

EID: 33745411104     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.02.018     Document Type: Article

References (46)

1. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 102 (1984) 1130-1134
2. The Committee for the Classification of the Late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 105 (1987) 906-912
3. Hughes S., Yang H., and Chan-Ling T. Vascularisation of the human fetal retina. roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41 (2000) 1217-1228
4. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of retinopathy of prematurity. three month outcome. Arch Ophthalmol 108 (1990) 195-204
5. The STOP ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (Stop ROP), a randomized clinical trial. primary outcomes. Pediatrics 105 (2000) 295-310
6. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indication for the treatment of retinopathy of prematurity. results of early treatment for ROP randomized trial. Arch Ophthalmol 121 (2003) 1684-1696
7. Ashton N. Retinal angiogenesis in the human embryo. Br Med Bull 26 (1970) 103-106
8. Chan-Ling T., McLeod S., Hughes S., et al. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol Vis Sci 45 (2004) 2020-2032
9. 165) expression by neuroglia. J Neurosci 15 (1995) 4739-4747
10. Chu Y., Hughes S., and Chan-Ling T. Astrocyte precursor cell (APCs) and astrocyte differentiation in embryonic human retina. relevance to optic nerve colobomas. FASEB J 15 (2001) 2013-2015
11. Holländer H., Makarov F., Dreher Z., van Driel D., Chan-Ling T., and Stone J. Structure of the macroglia of the retina. the sharing and division of labour between astrocytes and Müller cells. J Comp Neurol 313 (1991) 587-603
12. Hughes S., and Chan-Ling T. Characterization of smooth muscle cells and pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci 45 (2004) 2795-2806
13. Chan-Ling T. Glial, neuronal and vascular interactions in the mammalian retina. Prog Retin Eye Res 13 (1994) 357-389
14. Chan-Ling T, Hughes S. Cell-cell interactions in the formation of the human retinal vasculature. Mol Vis (Forthcoming).
15. Martin J., Kochanek K., Strobino D., Guyer B., and MacDormand M. Annual summary of vital statistics. Pediatrics 115 (2005) 619-634
16. Schaffer D.B., Johnson L., Quinn G.E., and Boggs T.R. A classification of retrolental fibroplasia to evaluate vitamin E therapy. Ophthalmology 86 (1979) 1749-1760
17. Quinn G.E., Schaffer D.B., and Johnson L. A revised classification of retinopathy of prematurity. Am J Ophthalmol 94 (1982) 744-749
18. Multicenter trial of cryotherapy for retinopathy of prematurity. manual of procedure (1985), National Technical Information Services, US Department of Commerce, Springfield (VA) No. PB 88-1653350
19. Gallagher K., Moseley M.J., Tandon A., Watson M.P., Cocker K.D., and Fielder A.R. Asymmetric location of retinopathy of prematurity in the nasal and temporal retina. Arch Ophthalmol 121 (2003) 1563-1568
20. Dreher B., and Robinson S.R. Development of the retinofugal pathway in birds and mammals. evidence for a common timetable. Brain Behav Evol 31 (1988) 369-390
21. Chan-Ling T., and Stone J. Retinopathy of prematurity. origins in the architecture of the retina. Prog Retin Eye Res 12 (1993) 155-178
22. Chan-Ling T., Gock B., and Stone J. The effect of oxygen on vasoformative cell division. evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 36 (1995) 1201-1214
23. 165 expression. Exper Eye Res 65 (1997) 555-568
24. Provis J.M., van Driel D., Billson F.A., and Russell P. Development of the human retina. patterns of cell distribution and redistribution in the ganglion cell layer. J Comp Neurol 233 (1985) 429-451
25. 165 allele. Nature 380 (1996) 435-439
26. 165 gene. Nature 380 (1996) 439-442
27. Cantolino S.J., O'Grady G.E., Herrera J.A., Israel C., Justice J., and Flynn J.T. Ophthalmoscopic monitoring of oxygen therapy in premature infants. fluorescein angiography in acute retrolental fibroplasia. Am J Ophthalmol 72 (1971) 321-331
28. O'Grady G.E., Flynn J.T., and Justice J. Fluorescein angiography in the study of retrolental fibroplasia. In: Shimazu K. (Ed). Fluorescein Angiography (1974), IgukaShoin Ltd, Tokyo 155-157
29. O'Grady G.E., Flynn J.T., Clarkson J., and Clark R.D. Retrolental fibroplasia. clinical fluorescein angiographic and pathologic correlation. Mod Probl Ophthalmol 12 (1974) 144-151
30. Flynn J.T. Acute proliferative retrolental fibroplasia. evolution of the lesion. Graefes Arch Clin Exp Ophthalmol 195 (1975) 101-111
31. Flynn J.T., O'Grady G.E., Herrera J., Kushner B.J., Cantolino S., and Milam W. Retrolental fibroplasia. I, clinical observations. Arch Ophthalmol 95 (1977) 217-223
32. Kushner B.J., Essner D., Cohen I.J., and Flynn J.T. Retrolental fibroplasia. II, pathological correlation. Arch Ophthalmol 95 (1977) 29-38
33. Flynn J.T., Cassady J., Essner D., et al. Fluorescein angiography in retrolental fibroplasia. experience from 1969-1977. Ophthalmology 86 (1979) 1700-1723
34. Flynn J.T., Bancalari E., Snyder E., et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 326 (1992) 1050-1054
35. Ashton N. Pathologic basis of retrolental fibroplasia. Br J Ophthalmol 38 (1954) 385-396
36. 165 in oxygen-induced retinopathy. Clin Exper Ophthalmol 28 (2000) 48-52
37. An international committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123 (2005) 991-999
38. Kivlin J., Biglan A., Gordon R., et al. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Arch Ophthalmol 114 (1996) 150-154
39. Rosenfeld P., Moshfeghi A., and Puliafito C. Optical coherence tomography after an intravitreal injection of bevacizumab. Ophthalmic Surg Lasers Imaging 36 (2005) 331-335
40. Michels S., Rosenfeld P., Puliafito C., Marcus E., and Venkatraman A. Systemic bevacizumab therapy for neovascular age-related macular degeneration. Ophthalmology 112 (2005) 1035-1047
41. Ozen S. Problems in classifying vasculitis in children. Pediatr Nephrol 20 (2005) 1214-1218
42. Martinelli G., Soverini S., Rosti G., and Baccalani M. Dual tyrosine kinase inhibitors in chronic myelogenous leukemia. Leukemia 19 (2005) 1872-1879
43. Nunes I., Higgens R., Zanetta L., Shamamian P., and Goff S. c-Abl is required for the development of hyperoxia-induced retinopathy. J Exp Med 193 (2001) 1383-1391
44. Shalak L., and Perlman J.M. Hypoxic-ischemic brain injury in the term infant. current concepts. Early Hum Dev 80 (2004) 125-141
45. Michaelson I.C. The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 68 (1948) 137-180
46. Cogan D.G. Doyne memorial lecture. development and senescence of human retinal vasculature. Trans Ophthalmol Soc UK 83 (1963) 465-489